EpiCast Report: Hyperparathyroidism - Epidemiology Forecast to 2025 - Product Image

EpiCast Report: Hyperparathyroidism - Epidemiology Forecast to 2025

  • ID: 4036438
  • Drug Pipelines
  • 57 pages
  • GlobalData
1 of 4
Hyperparathyroidism (HPT) is a disorder of the parathyroid gland that is caused due to presence of excessive parathyroid hormone (PTH) in the bloodstream (Mayo Clinic, 2015). The parathyroid glands are four small endocrine glands located on the posterior aspect of the thyroid gland in the neck. These glands are responsible for maintaining serum calcium concentrations, usually in the normal range of 8.5 to 10.2 mg/dl (Hall and Guyton, 2005).

The incidence and prevalence of HPT varies across populations, which can be attributed to the differences in the case-ascertainment criteria. People of all ages are at risk for HPT, although the condition is rarely seen in children. The presentation of the disease is demographically different between developing and developed countries; developing countries show more symptomatic diseases.

In the 7MM, epidemiologists forecast that the diagnosed prevalent cases of PHPT will increase from 2,055,167 cases in 2015 to 2,373,547 cases in 2025, at an Annual Growth Rate (AGR) of 1.55%. The US will have the highest number of cases of PHPT among the 7MM throughout the forecast period, while Japan will have the lowest.

Epidemiologists forecast that the total prevalent cases of SHPT will increase from 75,326,251 cases in 2015 to 85,592,876 cases in 2025, at an AGR of 1.36%. The US will have the highest number of total prevalent cases of SHPT among the 7MM throughout the forecast period, while Spain will have the lowest.

The report “EpiCast Report: Hyperparathyroidism - Epidemiology Forecast to 2025” provide an overview of the risk factors and global trends of HPT in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the diagnosed prevalent cases of primary HPT (PHPT), total prevalent cases for secondary HPT (SHPT) (including diagnosed and undiagnosed), and diagnosed prevalent cases of tertiary HPT (THPT), based on country-specific studies published in peer-reviewed journals.

The diagnosed prevalent cases of PHPT and total prevalent cases of SHPT are further segmented by sex and age (ages 20 years and above), and the diagnosed prevalent cases of THPT are segmented by sex. Epidemiologists also provide prevalent cases of SHPT in the total chronic kidney disease (CKD) pre-dialysis prevalent population and also in the total CKD dialysis prevalent population in the 7MM for the forecast period.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
1.1 List of Tables

1.2 List of Figures

2 Epidemiology

2.1 Disease Background

2.2 Risk Factors and Comorbidities

2.3 Global Trends

2.3.1 Prevalence

2.4 Forecast Methodology

2.4.1 Sources Used

2.4.2 Forecast Assumptions and Methods

2.4.3 Sources Not Used

2.5 Epidemiological Forecast of HPT (2015-2025)

2.5.1 Diagnosed Prevalent Cases

2.5.2 Total Prevalent Cases of SHPT

2.5.3 Diagnosed Prevalent Cases of THPT

2.6 Discussion

2.6.1 Epidemiological Forecast Insight

2.6.2 Limitations of the Analysis

2.6.3 Strengths of the Analysis

3 Appendix

3.1 Bibliography

3.2 About the Authors

3.2.1 Epidemiologists

3.2.2 Reviewers

3.2.3 Global Director of Therapy Analysis and Epidemiology

3.3 About

3.4 About EpiCast

3.5 Disclaimer

1.1 List of Tables

Table 1: Risk Factors and Comorbidities of HPT

Table 2: Diagnositc Criteria for PHPT, SHPT, and THPT

Table 3: 7MM, Sources Used to Forecast the Diagnosed Prevalent Cases of PHPT

Table 4: 7MM, Sources Used to Forecast the Total Prevalent Cases of SHPT

Table 5: 7MM, Sources Used to Forecast the Diagnosed Prevalent Cases of THPT

Table 6: 7MM, Sources Used to Forecast the Total Prevalent Cases of CKD

Table 7: 7MM, Diagnosed Prevalent Cases of PHPT, Ages =20 Years, Both Sexes, N, Selected Years 2015-2025

Table 8: 7MM, Age-Specific Diagnosed Prevalent Cases of PHPT, Ages =20 Years, Both Sexes, N (Row %), 2015

Table 9: 7MM, Sex-Specific Diagnosed Prevalent Cases of PHPT, Ages =20 Years N (Row %), 2015

Table 10: 7MM Total Prevalent Cases of SHPT, Ages =20 Years, Both Sexes, N, Selected Years 2015-2025

Table 11: 7MM, Age-Specific Total Prevalent Cases of SHPT, Both Sexes, N (Row %), 2015

Table 12: 7MM, Sex-Specific Total Prevalent Cases of SHPT, Ages =20 Years, N (Row %), 2015

Table 13: 7MM, SHPT in Pre-Dialysis CKD Total Prevalent Population (Stages 3-5), Ages =20 Years, Both Sexes, N, Selected Years 2015-2025

Table 14: 7MM, SHPT in Dialysis CKD Total Prevalent Population (Stage 5D), Ages =20 Years, Both Sexes, N, Selected Years 2015-2025

Table 15: 7MM, Diagnosed Prevalent Cases of THPT, Ages =20 Years, Both Sexes, N, Selected Years 2015-2025

Table 16: 7MM, Sex-Specific Diagnosed Prevalent Cases of THPT, Ages =20 Years, N (Row %), 2015

1.2 List of Figures

Figure 1: 7MM, Diagnosed Prevalent Cases of PHPT, Ages =20 Years, Both Sexes, N, Selected Years 2015-2025

Figure 2: 7MM, Age-Specific Diagnosed Prevalent Cases of PHPT, Ages =20 Years, Both Sexes, N, 2015

Figure 3: 7MM, Sex-Specific Diagnosed Prevalent Cases of PHPT, Ages =20 Years, 2015

Figure 4: 7MM, Age-Standardized Diagnosed Prevalent Cases of PHPT, Ages =20 Years, N, 2015

Figure 5: 7MM, Total Prevalent Cases of SHPT, Ages =20 Years, Both Sexes, N, Selected Years 2015-2025

Figure 6: 7MM, Age-Specific Total Prevalence of SHPT, Ages =20 Years, Both Sexes, N, 2015

Figure 7: 7MM, Sex-Specific Total Prevalent Cases of SHPT, Ages =20 Years, N, 2015

Figure 8: 7MM, Age-Standardized Total Prevalent Cases of SHPT, Ages =20 Years, N, 2015

Figure 9: 7MM, SHPT in Pre-Dialysis CKD Total Prevalent Population (Stages 3-5), Ages =20 Years, Both Sexes, N, Selected Years 2015-2025

Figure 10: 7MM, SHPT in Dialysis CKD Total Prevalent Population (Stages 5D), Ages =20 Years, Both Sexes, N, Selected Years 2015-2025

Figure 11: 7MM, Diagnosed Prevalent Cases of THPT, Ages =20 Years, Both Sexes, N, Selected Years 2015-2025

Figure 12: 7MM, Sex-Specific Diagnosed Prevalent Cases of THPT, Ages =20 Years, N, 2015
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll